HIMS Hims & Hers Health, Inc.: institutional ownership and insider trading
546 funds reported holding $8.77B of Hims & Hers Health, Inc. in their latest 13F filings; in Q2 2026 funds net bought $240M, with 142 new positions and 65 funds selling out; over the last 12 months insiders bought $1.17M and sold $19.4M on the open market; over its last four quarters it reported revenue of $2.58B and net income of −$142M.
HIMS revenue and earnings
- Quarter ended Jun 30, 2026: revenue $753M, net income −$86.3M, EPS -0.37
- Quarter ended Mar 31, 2026: revenue $608M, net income −$92.1M, EPS -0.40
- Quarter ended Dec 31, 2025: revenue $618M, net income $20.6M, EPS 0.08
- Quarter ended Sep 30, 2025: revenue $599M, net income $15.8M, EPS 0.06
Famous investors holding HIMS
- D. E. Shaw (D. E. Shaw & Co.): $179M, 0.1% of the portfolio
- Ken Griffin (Citadel Advisors): $348M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $23.2M, 0.0% of the portfolio
- Ray Dalio (Bridgewater Associates): $244K, 0.0% of the portfolio
Largest institutional holders of HIMS
- BlackRock, Inc. (BLK) — $995M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $783M
- VANGUARD GROUP INC — $679M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $366M
- CITADEL ADVISORS LLC — $348M
- JANE STREET GROUP, LLC — $345M
- VANGUARD CAPITAL MANAGEMENT LLC — $331M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $292M
- STATE STREET CORP (STT, STT-PG) — $282M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $248M
Recent HIMS insider trades
- Oct 14, 2026: Boughton Soleil sold 3,461 shares ($101K)
- Oct 1, 2026: Okupe Oluyemi sold 2,000 shares ($59.4K)
- Sep 30, 2026: Boughton Soleil sold 3,461 shares ($101K)
- Sep 22, 2026: Okupe Oluyemi sold 29,277 shares ($877K)
Members of Congress trading HIMS
- Aug 4, 2025: Lisa C. McClain bought $1.00K–$15.0K
5%+ owners
- BlackRock, Inc.: 11.9% (Schedule 13G/A, filed Jul 28, 2026)
- Andrew Dudum: 9.4% (Schedule 13D/A, filed Aug 31, 2026)
- G1 Execution Services, LLC: 6.5% (Schedule 13G, filed May 15, 2026)
- Vanguard Capital Management: 5.0% (Schedule 13G, filed Jul 31, 2026)